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ABSTRACT
Cisplatin is a chemotherapeutic agent widely used in treating various types of cancer. However, its usage is restricted 
due to the adverse hepatoxicity, as seen in approximately 36% of cancer patients receiving cisplatin treatment. 
Polygonum minus essential oil has high antioxidant capacity, and is enriched with terpenoids and phenolic compounds. 
The objective of this study was to investigate effects of P. minus essential oil (PmEO) supplementation on cisplatin-
induced hepatotoxicity in rats. Male rats were divided into seven different groups, namely: control (C), cisplatin-
induced (CP), positive control with β-caryophyllene 150 mg/kg (BCP), PmEO 100 mg/kg (PmEO100CP), PmEO 200 
mg/kg (PmEO200CP), PmEO 400 mg/kg (PmEO400CP) and PmEO 400 mg/kg alone (PmEO400). PmEO and BCP 
was given orally for 14 days prior to a single dose cisplatin (10 mg/kg) injection on day 15 and rats were sacrificed 
on day 18. Liver enzymes, histology, ultrastructural morphology and oxidative stress markers such as glutathione, 
glutathione peroxidase, catalase, superoxide dismutase and malondialdehyde were assayed. Compared to controls, 
levels of transaminase enzymes, serum bilirubin and oxidative stress were all increased in CP, PmEO200CP and 
PmEO400CP groups. However, only PmEO100CP and BCP groups reduced these increases in level of transaminase 
enzymes and oxidative stress compared to CP group. On both light microscopic and ultrastructural examination, CP 
and PmEO400CP groups showed hepatotoxicity, exhibited by cytoplasmic vacuolation, congested blood sinusoids 
and increased number of Kupffer cells. However, these changes were minimized in the PmEO100CP group. Therefore, 
we concluded that PmEO given at 100 mg/kg has preventive effect against cisplatin-induced hepatotoxicity in rats. 
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ABSTRAK
Cisplatin adalah agen kemoterapi yang digunakan secara meluas untuk merawat pelbagai jenis kanser. Walau 
bagaimanapun, penggunaannya adalah sangat terhad disebabkan oleh berlakunya kehepatoksikan dalam kalangan 
kira-kira 36% pesakit kanser yang menerima rawatan cisplatin. Minyak pati Polygonum minus mempunyai keupayaan 
antioksidan yang tinggi dan diperkaya dengan terpenoid dan sebatian fenolik. Objektif kajian ini adalah untuk mengkaji 
kesan suplemen minyak pati P. minus (PmEO) ke atas cisplatin-aruhan kehepatoksikan di dalam tikus. Tikus jantan 
dibahagikan kepada tujuh kumpulan yang berbeza iaitu: kawalan (C), cisplatin-aruhan (CP), kawalan positif dengan 
β-caryophyllene 150 mg/kg (BCP), PmEO 100 mg/kg (PmEO100CP), PmEO 200 mg/kg (PmEO200CP), PmEO 400 
mg/kg (PmEO400CP) dan PmEO 400 mg/kg sahaja (PmEO400). PmEO dan BCP diberikan secara oral selama 
14 hari sebelum dos tunggal cisplatin (10 mg/kg) disuntik pada hari ke 15 dan tikus dikorbankan pada hari ke 18. 
Enzim hati, histologi, morfologi ultrastruktur dan penunjuk tekanan oksidatif seperti glutation, glutation peroksida, 
katalase, superoksida dismutase dan malondialdehid diasai. Berbanding dengan kawalan, tahap enzim transaminase, 
serum bilirubin dan tekanan oksidatif semuanya meningkat dalam kumpulan CP, PmEO200CP dan PmEO400CP. 
Walau bagaimanapun, hanya kumpulan PmEO100CP dan BCP mengurangkan tahap enzim transaminase dan tekanan 
oksidatif berbanding tikus aruhan cisplatin. Bagi kedua-dua pemeriksaan mikroskopik dan ultrastruktur, kumpulan 
CP dan PmEO400CP menunjukkan kehepatoksikan yang ditunjukkan oleh vakuolasi sitoplasma, sinusoid darah 
yang tersumbat dan peningkatan bilangan sel Kupffer. Walau bagaimanapun, perubahan ini diminimumkan dalam 
kumpulan PmEO100CP. Oleh itu, kami membuat kesimpulan bahawa PmEO diberikan pada 100 mg/kg mempunyai 
kesan pencegahan terhadap cisplatin-aruhan kehepatoksikan dalam tikus.
Kata kunci: Agen kemoterapi; cisplatin; enzim hati; ketoksikan hati; Polygonum minus
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INTRODUCTION
Cisplatin or cis-diamminedichloroplatinum (II) is a 
platinum complex with anticancer activity against various 
types of tumours including solid tumours of the head 
and neck and cancers in the reproductive system such 
as ovaries and testes (Katzung 2004). It is also clinically 
used to treat cancer of blood vessels, muscles, bones and 
soft tissue (Desoize 2002). Nevertheless, the therapeutic 
usage of cisplatin is particularly restricted due to side 
effects such as hepatotoxicity (El-Sayyad et al. 2009; 
Liao et al. 2008), nephrotoxicity (Pabla & Dong 2008), 
ototoxicity (Rybak et al. 2009) and neurotoxicity (Barabas 
et al. 2008). It is now known that cisplatin significantly 
accumulates within human liver after administration 
and a high dose of the cisplatin produces hepatotoxicity 
characterized by impaired liver function, elevated levels 
of enzymatic biomarkers such as alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST) (Palipoch & 
Punsawad 2013), as well as hepatic necrosis, pericentral 
disorganization, and apoptotic changes (Attyah & Ismail 
2012). Transaminases are the most suitable biomarkers 
of liver toxicity and cellular disruption because they are 
located in the cytoplasm and are only secreted into the 
circulation after cellular disruption (İşeri et al. 2007). 
Increase in hepatic enzymes level in serum and bilirubin 
are also markers of perturbed liver function (Nasr 2013). 
El-Sayyad et al. (2009) and Kart et al. (2010) showed that 
cisplatin induced severe anomalies in liver tissue histology 
and the ultrastructure. Whilst the mechanisms underlying 
cisplatin-induced hepatoxicity remains poorly understood, 
oxidative stress is thought to primarily mediate cisplatin-
induced hepatotoxicity (Cetin et al. 2011). 
 In recent years, various natural products and medicinal 
plants were extensively studied for protective effects 
against human diseases and illnesses. These include 
Zingiber zerumbet (Hamid et al. 2018), leaves of Plantago 
major (Hussan et al. 2015), Malaysian gelam honey 
(Lee et al. 2011) and Hibiscus sabdariffa (Idris et al. 
2012) as potential protective agents and were proven to 
have high antioxidant capacity both in vivo and in vitro. 
Polygonum minus (syn. Persicaria minor), commonly 
known as kesum, is usually used as a folk medicine and 
flavoring ingredient in South East Asia countries, such 
as Vietnam, Laos, Indonesia and Thailand (Qader et al. 
2011). It is an aromatic plant containing aliphatic aldehydes 
and according to Baharum et al. (2010), may produce 
high levels of essential oil (~72.54%). Furthermore, 
Ahmad et al. (2014) found that terpenoid metabolites 
were discovered in the leaves but not in the stem and 
root of this plant. A total of 35 terpenes were identified 
in the essential oil of P. minus, including a-humulene, 
a-curcumene β-caryophyllene, d-cadinene, farnesol 
and nerolidol (Baharum et al. 2010). Therapeutically, 
these sesquiterpenes were reported as anti-inflammatory 
agents (Fernandes et al. 2007), selective anticancer and 
antimicrobial agents against colorectal malignancies 
(Dahham et al. 2015) and cancer chemopreventive agents 
that protect cells from oxidant-induced DNA injury (Devi 
et al. 2015) and antioxidant (Khan & Sultana 2011) in both 
in vivo and in vitro settings. Despite these observations, 
it remains unclear whether P. minus essential oil can 
exert protect against cisplatin-induced hepatotoxicity and 
attenuate associated oxidative stress and ultrastructure 
damage in the liver. 
 The purpose of the present study was therefore to 
evaluate possible protective effect of P. minus essential 
oil (PmEO) on cisplatin-induced hepatotoxicity in adult 
male rats.
MATERIALS AND METHODS
EXTRACTION OF ESSENTIAL OIL
P. minus leaves were harvested from a local farm and 
authenticated at the Institutional Herbarium Department 
(No. UKMB40332). Fresh whole leaves (10 kg) of P. 
minus were subjected to hydrodistillation with 40 L of 
distilled water for 8 h using a Clevenger-type apparatus 
as previously described by Ahmad et al. (2014). Essential 
oil was collected over distilled water, separated, dried over 
nitrogen gas prior to storage in dark at 4°C. 
GAS CHROMATOGRAPHY-MASS                            
SPECTROMETRY (GC-MS) ANALYSIS
For identification of volatile compounds in PmEO, 
samples were analyzed using the Clarus 600 GC-MS 
system (PerkinElmer, USA) (Ahmad et al. 2014). Volatile 
compounds were separated using a 30 m×0.25 mm×0.25 
μm Elite-5MS column. The injector port was heated to 
250°C and the carrier gas was helium at a constant flow of 
1 mL·min-1. All mass spectra were acquired in the electron 
impact mode (EI). The MS parameters were as follows: 
EI mode, an ionization voltage of 70 eV, an ion source 
temperature of 200°C and a scan range of 40 – 600 Da. 
The peaks were tentatively identified based on a library 
search using NIST and Wiley Registry 8 Edition. 
EXPERIMENTAL DESIGN
Male Sprague Dawley rats (n = 42, 180 - 200 g) were 
kept in polypropylene cages with good ventilation under 
standard conditions (12/12 light/dark cycle at 21 ± 2°C and 
50 - 70% humidity) and were acclimatized for 7 days before 
treatments. Standard rodent pellet and tap water were 
provided ad libitum. Rats were divided into seven different 
groups: control (C), cisplatin-induced (CP), positive control 
i.e. β-caryophyllene 150 mg/kg + cisplatin-induced (BCP), 
PmEO 100 mg/kg + cisplatin-induced (PmEO100CP), 
PmEO 200 mg/kg + cisplatin-induced (PmEO200CP), 
PmEO 400 mg/kg + cisplatin-induced (PmEO400CP) and 
PmEO 400 mg/kg alone (PmEO400). Doses, duration of 
essential oil and β-caryophyllene was given according to 
Damião et al. (2013), Ebada (2018) and Cho et al. (2007). 
PmEO were given orally for 14 consecutive days prior to 
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a single dose of cisplatin (10 mg/kg ip.) injection on day 
15. All animals were sacrificed on day 18. Blood samples 
were collected directly via cardiac puncture and transferred 
into separate test tubes. Liver tissues were excised, rinsed 
gently with ice-cold normal saline, weighed and divided 
into four parts for further analyses. The liver weight/body 
weight ratio was calculated according to the following 
formula, organ ratio (%) = organ weight × 100/body weight 
(Nasr 2013). All animal procedures adhered to the ethical 
approval from institutional animal ethnical committee (FP/
ANAT/2014/FAIZAH/26-NOV./632-NOV.-2014-SEPT.-2017).
LIVER BIOMARKERS
Blood sample was centrifuged at 3000 rpm for 15 min, 
and the serum was separated and used within 48 h for 
estimation of transaminase enzymes. ALT and AST activity 
were estimated by assessing the amount of pyruvate or 
oxaloacetate produced (Nasr 2014). Alkaline phosphatase 
(ALP) and bilirubin were measured as previously described 
(Sarhan et al. 2014; Schmidt & Eisenburg 1975).
ANALYSIS OF LIVER OXIDATIVE STRESS
A portion of rat liver was homogenized in 10% phosphate 
buffer saline (0.05 M, pH7.4) and centrifuged at 15,000 
× g for 15 min at 4°C. The supernatant was collected and 
used for measurement of GSH, SOD Cat, GPx, MDA, protein 
carbonyl and 8-hydroxydeoxyguanosine (8-OHdG). The 
antioxidant markers GSH, SOD Cat, GPx, MDA, protein 
carbonyl and 8-OHdG were all measured using commercial 
ELISA kits (Cayman Chemical, USA and Elabscience, 
China) according to the manufacturer guidelines. 
HISTOLOGY
Liver tissues were fixed in 10% neutral formalin for 48 h, 
processed in ascending grades of alcohol and embedded 
in paraffin blocks. Sections of 4 μm were obtained from 
the prepared blocks using a microtome (Leica RM2135, 
Germany) and stained with haematoxylin and eosin. 
These preparations were visualized using a Leica DMRXA2 
microscope (Germany).
ELECTRON MICROSCOPIC EXAMINATION
Liver tissues (1 mm3) from each animal were cut and 
immersed in 3% glutaraldehyde in 0.1 M phosphate buffer 
at 4°C and were fixed in 1% osmium tetraoxide for 2 h 
at 4°C (Nasr 2013). The samples were dehydrated via 
ascending grades of ethanol, treated with a propylene oxide 
solution and embedded in a mixture of 1:1 Epon-Araldite 
for 1 h. Samples were polymerized for 24 h at 65°C. One 
µm sections were cut, mounted on glass slides and stained 
with buffered toluidine blue. Appropriate areas were 
selected and cut (50 - 60 nm), then mounted on copper 
grids, double stained with uranyl acetate and lead citrate 
to examine under the electron microscope (FEI TECNAI 
BIOTWIN, 120 kv, Netherland).
STATISTICAL ANALYSIS
All values are expressed as means ± SEM after analysis 
using Statistical Package for the Social Sciences version 23 
(SPSS Inc, IL, USA). The data with homogeneous intra-group 
variances were subjected to one-way analysis variance 
(ANOVA) followed by post-hoc Tukey’s test. P value of 0.05 
or less was considered statistically significant.
RESULTS
VOLATILE COMPOUND OF LEAVES FROM                                      
P. minus ESSENTIAL OIL
Most of the volatiles compounds identified in P. minus 
yellowish-essential oil were aldehydes, sesquiterpenes and 
organic acids as shown in Table 1. A total of 37 compounds 
were identified; with dodecanal and decanal being the most 
dominant compounds (39.4% and 10.4%, respectively). 
Sesquiterpene identified in the P. minus essential oil include 
8.61% cyclolongifolene oxide, 3.3% α-caryophellene, 
1.13% α-bergamotene, 0.72% seychellene, 0.63% 
β-caryophellene, 0.58% velencene, 0.56% drimenol. 
The relative concentrations of several classes of volatile 
compounds identified in P. minus essential oil are shown 
in Table 2.
EFFECT OF CISPLATIN AND PMEO ON MORTALITY              
RATE AND TOXICITY IN RATS
Table 3 shows the mortality rate and toxicity symptoms 
observed in experimental rats. Regardless of type of 
treatment, no mortality was observed in all experimental 
groups at endpoint. Cisplatin and PmEO400CP-induced 
rats exhibited cholinergenic toxicity symptoms such as 
lacrimation, tremor, piloerection, reduced food and drink 
intake and hypoactivity on day 18. No signs of toxicity 
were however observed in control rats. Food and water 
intake on the day 18 was significantly reduced in CP, BCP, 
PmEO200CP and PmEO400CP groups compared to the 
controls and PmEO400-treated rats (Table 4).
EFFECT OF CISPLATIN AND PMEO ON BODY                            
WEIGHT OF RATS
There was a significant reduction (p < 0.05) in the body 
weight of CP group compared to the control group on day 
17 and 18 (Figure 1). Combination of PmEO (all doses) 
and BCP with cisplatin also caused a significant (p < 0.05) 
reduction in body weight of rats compared to control rats 
on day 17 and 18.
EFFECT OF CISPLATIN AND PMEO ON                                     
LIVER WEIGHT IN RATS
Effects of PmEO on the liver weight and liver weight-
to-body weight ratio in rats are shown in Table 5. Both 
liver weight and liver weight-to-body weight ratio were 
significantly reduced in cisplatin-induced rats compared 
to the control rats (p < 0.05). However, liver weight/
body weight ratio was significantly increased in BCP, 
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TABLE 1. Volatile compound of P. minus leaves in essential oil
Peak 
No.
Compound* Retention 
time
Percentage**
1
2
3
4
5
6
Aldehyde
 Decanal
 Undecanal
 Dodecanal
 Tetradecanal
 Pentadecanal
 Hexadecanal
14.791
17.469
20.348
24.95
38.172
39.914
10.396
0.503
39.384
1.194
0.309
0.681
7
8
9
10
Alcohol
 1-Dodecanol
 1-Undecanol
 1-Dodecen-3-ol
 a-(Z)-Bergamotol
19.073
22.382
33.285
24.793
0.957
1.092
0.282
0.046
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Terpenoid (sesquiterpene)
 Isocaryophyllene
 α-Bergamotene
 α-Caryophyllene
 Seychellene
 β-Farnesene
 Velencene
 α-Bergamotene
 α-Panasinsen
 α-Bergamotene
 β-Caryophyllene
 trans-Z-α-Bisabolene epoxide
 Cyclolongifolene oxide
 β-Bisabolol
 Drimenol
 Isolongifolol
 Drimenin
19.843
20.614
21.208
21.787
21.099
21.989
22.695
22.695
23.337
24.198
24.859
25.601
26.243
28.774
28.774
34.999
0.438
0.66
3.294
0.72
0.476
0.576
0.299
0.279
0.169
0.627
0.192
8.608
0.277
0.557
0.342
0.386
27
28
29
30
31
Organic acid
 Dodecanoic acid
 4,7-Octadecadiynoic acid 
 Hexadecanoic acid
 α-Linolenic acid
 Octadecanoic acid
25.739
33.44
33.633
36.631
37.016
2.457
0.703
1.87
1.935
0.279
32
33
34
35
36
37
Aliphatic compound
 Naphthalenone, 3, 5, 6, 7, 8, 8a-octahydro-2,5,8a-6-(1-methylethenyl)-
 Phytol
 1H-Inden-1-one,5-(1,1-dimethylethyl)-2,3-dihydro-3,3-dimethyl
 3,7,11,14,18-Pentaoxa-2,19-disilaeicosane,2,2,19,19-tetramethyl-
 Eicosane
 Bicyclo[4.3.0]nonane, 5a-iodomethyl-1a-isopropenyl-4a,5a-dimethyl-
31.167
35.824
37.2
40.821
41.161
41.665
0.24
0.806
0.807
0.355
0.212
0.618
*As identified by GC-MS Software; names according to NIST mass spectral library. **Percentage of each compound is calculated as peak area of analyte 
divided by peak area of total ion chromatogram multiply by 100
TABLE 2. The relative concentrations of volatile                      
compounds in P. minus essential oil
Chemical class of compound Essential oil
% Relative area
Aldehyde
Sesquiterpenes
Organic Acid
Aliphatic compound
Alcohol
52.47
17.9
7.24
3.04
2.38
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TABLE 3. Mortality and toxicity symptoms in cisplatin                                 
and PmEO-induced rats
Group Mortality Toxicity symptom
Control 0/6 None
Cisplatin 0/6 Lacrimation (n=2)
Tremor (n=0)
Piloerection (n=6)
Drink a lot (n=2)
Less food intake (n=6)
Hipoactivity (n=6)
BCP 0/6 Lacrimation (n=0)
Tremor (n=0)
Piloerection (n=3)
Drink a lot (n=2)
Less food intake (n=5)
Hypoactivity (n=3)
PmEO100CP 0/6 Lacrimation (n=0)
Tremor (n=0)
Piloerection (n=4)
Drink a lot (n=2)
Less food intake (n=5)
Hypoactivity (n=3)
PmEO200CP 0/6 Lacrimation (n=0)
Tremor (n=0)
Piloerection (n=6)
Drink a lot (n=1)
Less food intake (n=5)
Hypoactivity (n=6)
PmEO400CP 0/6 Lacrimation (n=2)
Tremor (n=0)
Piloerection (n=6)
Drink a lot (n=0)
Less food intake (n=6)
Hypoactivity (n=6)
PmEO400 0/6 Lacrimation (n=0)
Tremor (n=0)
Piloerection (n=0)
Drink a lot (n=0)
Hypoactivity (n=6)
TABLE 4. Effects of cisplatin and PmEO on food and drink intake in rats
Group Control Cisplatin BCP PmEO100CP PmEO200CP PmEO400CP PmEO400
Food intake Day 15
Food intake Day 18
Drink intake Day 15 
Drink intake Day 18
21.6 ± 1.3
24.0 ± 1.1
30.3 ± 2.6
30.0 ± 1.9
21.3 ± 1.5
3.8 ± 1.4a
31.0 ± 1.0
19.3 ± 6.5
19.5 ± 1.7
6.0 ± 2.1a
26.8 ± 3.0
18.3 ± 3.9
23.9 ± 1.1
4.1 ± 2.5a
31.0 ± 1.1
29.8 ± 2.8
20.2 ± 1.4
3.3 ± 2.2a
32.8 ± 1.5
12.3 ± 4.1ad 
20.1 ± 1.5
3.8 ± 2.1a
33.3 ± 3.1
11.0 ± 2.7ad
20.6 ± 1.5
21.2 ±0.4bcdef
34.3 ± 2.8
32.3 ±1.6ef
Data are expressed as mean ± SEM (n = 6). Food intake and drink intake are expressed in g/day/rat. aSignificantly different from control rats (p < 0.05). bSignificantly 
different from cisplatin-induced rats (p < 0.05). cSignificantly different from BCP-treated rats (p < 0.05). dSignificantly different from PmEO100CP-treated rats (p < 0.05). 
eSignificantly different from PmEO200CP-treated rats (p < 0.05). fSignificantly different from PmEO400CP-treated rats (p < 0.05)
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FIGURE 1. Effects of cisplatin and PmEO on body weight (g) in rats (Mean ± SEM). CP group is asignificantly 
different from Control group at p < 0.05 on the day 17 and 18. Weight of BCP, PmEO+Cisplatin-induced 
group (PmEO100CP, PmEO200CP, PmEO400CP) is asignificantly reduced at p < 0.05 on the day 17 and 
18 compared to Control. Meanwhile PmEO100CP is bsignificantly different at p < 0.05 on the day 18 
compared to CP group. However, PmEO400 showed significant difference against control 
and CP group at p < 0.05 on the day 15, 17 and 18
TABLE 5. Effects of cisplatin and PmEO on liver weight and liver weight/body weight ratio in rats
Group Control Cisplatin BCP PmEO100CP PmEO200CP PmEO400CP PmEO400
Liver Weight (g) 12.10 ± 0.38 7.20 ± 0.09a 8.80 ± 0.64ab 9.75 ± 0.23ab 9.00 ± 0.13ab 8.97 ± 0.17ab 10.30 ± 0.41ab
Final Body 
Weight (g)
300.50 ± 
9.90
201.83 ± 
3.50a
227.50 ± 
12.40a
242.17 ± 
9.30ab
224.17 ± 
2.98a
221.83 ± 
9.50a
255.33 ± 
9.94ab
Liver weight/
body weight 
Ratio (%)
4.03 ± 0.01 3.52 ± 0.02a 3.85 ± 0.09b 4.04 ± 0.06b 4.00 ± 0.02b 4.06 ± 0.10b 4.03 ± 0.03b
Data are expressed as mean ± SEM (n = 6). Liver weight/body weight ratio = liver weight (g) × 100/body weight (g). aSignificantly different from control rats (p < 0.05). 
bSignificantly different from cisplatin-induced rats (p < 0.05)
PmEO100CP, PmEO200CP and PmEO400CP and 
PmEO400 group compared to CP group. 
EFFECT OF CISPLATIN AND PMEO ON LIVER                 
BIOMARKERS IN RATS
ALP, AST, ALT, conjugated bilirubin and total bilirubin levels 
were all significantly increased in the PmEO400CP and 
cisplatin-induced rats when compared to the control rats at 
p < 0.05. However, a significant reduction (p < 0.05) was 
observed for ALP, AST and ALT in PmEO100 and PmEO200 
groups when compared to the cisplatin-induced rats. Liver 
biomarkers (ALP, ALT, conjugated bilirubin and total 
bilirubin) were all significantly elevated in PmEO200CP, 
PmEO400CP and PmEO400 groups compared to BCP 
and PmEO100CP-treated rats. PmEO400CP also showed 
a significant increase in serum bilirubin as compared to 
the PmEO200CP group. PmEO400 alone group showed 
a significant reduction (p < 0.05) in AST, ALT and serum 
bilirubin as compared to cisplatin-induced rats (Figure 2). 
EFFECT OF CISPLATIN AND PMEO ON OXIDATIVE STRESS
GSH, SOD, and GPx activities significantly lowered in CP, 
PmEO200 and PmEO400 groups when compared to the 
control, BCP and PmEO100CP groups. CAT activity level 
was also lowered in CP, PmEO200CP and PmEO400CP 
groups compared to the control and BCP-treated rats (p < 
0.05). MDA, protein carbonyl and 8-OHdG levels were 
significantly increased in CP, PmEO200 and PmEO400 
groups compared to the control and BCP-treated rats (p 
< 0.05) indicating enhanced lipid peroxidation, protein 
oxidation and oxidant-induced DNA damage. However, 
the levels of GSH, GPx, CAT, SOD and MDA showed no 
significant difference against BCP, PmEO100CP and 
control rats. A significant reduction (p < 0.05) was 
observed in all oxidative stress marker (GSH, GPx, CAT, 
SOD, MDA) in control, BCP and PmEO100CP compared to 
CP group (Figure 3). 
EFFECT OF CISPLATIN AND PMEO ON LIVER HISTOLOGY
Liver histology with haematoxylin and eosin staining 
as shown in Figure 4(a); showed control hepatic tissues 
with well-organized radiating cords of hepatocytes around 
the central vein and narrow sinusoids. Endothelial cells 
and Kupffer cells were well lined in the blood sinusoids. 
Unlike this, the group receiving cisplatin (Figure 4(b)) 
showed dilatation and congestion of central vein and blood 
sinusoids in the liver. Accumulation of inflammatory 
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cells and apoptotic nuclei were also observed in the 
centrilobular zone. In BCP group and PmEO100CP-treated 
rats (Figure 4(c), 4(d)), a well-organized radiating cords 
of hepatocytes around the central vein were observed. 
However, mild dilatation of blood sinusoids with relative 
increase in the number of binucleated hepatocytes and 
Kupffer cells were observed. PmEO200CP-treated 
rats showed dilated blood sinusoids (Figure 4(e)) with 
increased number of Kupffer cells and binucleated cells, 
along with poorly-organized hepatocytes. PmEO400CP-
treated rats (Figure 4 (f)) showed dilated blood sinusoids 
around the congested and dilatation of central vein. The 
hepatocytes were not well-organized and apoptotic nuclei 
can be easily seen in the centrilobular zone. PmEO400 
(Figure 4(g)) showed mild dilatation of blood sinusoids 
with increase number of Kupffer cells and the hepatocytes 
were disorganized.
EFFECT OF CISPLATIN AND PMEO ON                            
ELECTRON MICROSCOPIC STUDY
Electron microscopic examination showed normal 
polygonal-shaped hepatocytes with central oval nucleus 
in the control rats (Figure 5(a)). The nucleus exhibited 
a discontinued nuclear envelope, thick nucleolus and 
condensed heterochromatin on the inner side of the 
nuclear envelope around the nuclear pores. Round and 
oblong-shaped mitochondria were scattered in groups, with 
parallel rough endoplasmic reticulum (RER) cisternae, few 
lysosomes and glycogen masses and hepatocyte membrane 
in normal hepatocytes. In cisplatin-induced rats, however, 
the central nucleus was tremendously irregular in shape 
(Figure 5(b)) and the nucleus exhibited few variable-
sized of heterochromatin masses on the inner side of the 
nuclear envelope. Increased number of variable sizes 
and shapes of mitochondria along with vesicular dilated 
FIGURE 2. Effect of cisplatin and PmEO on liver biomarkers in rats. Values are mean ± SEM (n = 6). aSignificantly 
different from Control group at p < 0.05; bSignificantly different from CP group at p < 0.05. cSignificantly different 
from BCP group at p < 0.05. dSignificantly different from PmEO100CP group at p < 0.05. eSignificantly different 
from PmEO200CP group at p < 0.05. fSignificantly different from PmEO400CP group at p < 0.05. ALP - alkaline 
phosphatase, ALT - alanine aminotransferase, AST - aspartate aminotransferase
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RER were seen inside the cytoplasm of the hepatocyte. 
In BCP and PmEO100CP groups, the hepatocytes had 
a regular polygonal shape and large oval nucleus with 
thick nucleolus (Figure 5(c), 5(d)). Numerous round 
mitochondria, parallel RER cisternae, lysosomes, glycogen 
masses and hepatocyte membrane were also observed in 
both BCP and PmEO100CP-treated rats. In PmEO200CP-
treated rats (Figure 5(e)), the nucleus exhibited irregular 
shape of envelope with dense heterochromatin and fewer 
mitochondria were seen to fill in the space of the cytoplasm 
as compared to BCP and PmEO100CP-treated rats. A 
macrophage, large-sized of phagosome and vesicular 
dilated RER cisternae were also observed in the cytoplasm as 
well. In PmEO400CP-treated rats, the hepatocytes attained 
small size and a central nucleus with irregular outline 
(Figure 5(f)). The nuclear part showed a little amount of 
condensed heterochromatin within the nucleoplasm. Few 
lysosomes, round mitochondria and vesicular dilated RER 
cisternae were observed in PmEO400CP-treated rats. 
PmEO400-treated rats (Figure 5(g)) showed congested 
cytoplasm with rounded mitochondria and RER cisternae. 
Few lysosomes and hepatocyte membrane also can be seen.
DISCUSSION
Cisplatin is a prominent anticancer drug mainly used to 
treat solid tumors. However, its usage is limited due to 
toxicity on the liver, seen on approximately 36% of cancer 
patients after a single dose of treatment (Al-Malki & Sayed 
2014). El-Sayyad et al. (2009) stated that the liver is known 
FIGURE 3. Effect of cisplatin and PmEO on liver antioxidant enzymes and lipid peroxidation in rats. Values are mean 
± SEM (n = 6). aSignificantly different from Control group at p < 0.05; bSignificantly different from CP group at p < 
0.05. cSignificantly different from BCP group at p < 0.05. dSignificantly different from PmEO100CP group at p < 0.05. 
eSignificantly different from PmEO200CP group at p < 0.05. fSignificantly different from PmEO400CP group at p < 0.05
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to accumulate significant amount of cisplatin, after kidney. 
Therefore, hepatotoxicity can occur easily after high dose 
administration of cisplatin (10 mg/kg) treatment (Koc et 
al. 2005). According to Nair and Jacob (2016), the 10 mg/
kg dose is used in clinical practice and parallels to 70 mg/
m2 in a human being (60 kg).
  Dodecanal and decanal, the two main aldehydes 
which constitutes to the flavour of P. minus were found 
as most-concentrated compound in the essential oil used 
in this study. Our findings were similar to Ahmad et al. 
(2014), Baharum et al. (2010) and Rusdi et al. (2016). 
Ahmad et al. (2014) also found most of the terpenoids 
identified by GC-MS were majorly present in leaves 
compared to the stems and roots because aerial parts of 
the plant are exposed to oxidative stress, high temperatures 
and have a photosynthetic function. According to Opitz 
FIGURE 4. Histological changes in the rat liver. (A) A control liver with normal architecture of radiating hepatocyte-cords (H) around 
the central vein (CV) and narrow blood sinusoids (S) with few binucleated hepatocytes (B2). Endothelial cells and Kupffer cells (K) 
lined in the blood sinusoids; (B) Dilated congested central vein and blood sinusoids, few Kupffer cells and apoptotic nuclei (AN) can 
be seen with accumulation of inflammatory cells (N) appear in the CP group; (C) BCP group shows almost similar architecture of 
hepatocytes with control group; (D) narrow blood sinusoids with endothelial cells (E), increasing number of Kupffer cells and binucleated 
hepatocytes were seen in PmEO100CP group; (E) Mild dilated blood sinusoids, few Kupffer cells with binucleated hepatocytes were 
observed in PmEO200CP group; (F) Dilated congested blood sinusoids, Kupffer cells, binucleated hepatocytes and apoptotic nuclei 
can be seen in PmEO400CP group; and (G) PmEO400 shows dilated blood sinusoids, increasing number of 
Kupffer cells and irregular structure of central vein (Hematoxylin and eosin ×400; scale bars 50 μm)
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et al. (2008), a large variety of terpenes are produced 
in all photosynthetically active parts of the plants and 
stored in the subepidermal gland. Furthermore, Peñuelas 
and Llusiá (2002) stated that temperature increases the 
emission and production rates of most terpenes and can 
replace photorespiration of the plant in protection from 
photodamage by scavenging oxygen-reactive species; 
likely explaining our observations in this study.
  Abdelhafiz et al. (2014), Cetin et al. (2011) and Dkhil 
et al. (2013) and stated that using a plant-derived-material 
can protect against cisplatin-induced hepatotoxicity. P. 
minus is one of those candidate plants due to high level of 
FIGURE 5. Ultrastructural changes in the liver of rats. (A) The normal hepatocyte has a central oval nucleus (N) with electron dense 
nucleolus (n). The cytoplasm contains numerous oblong and round-shaped mitochondria (M), few lysosomes (Lys), rough endoplasmic 
reticulum cisternae (RER) and variable sizes of glycogen masses (GM) located between the mitochondria. The biliary surface of the 
hepatocyte membrane (cm) also can be seen. Condensed heterochromatin masses (ch) were seen within the nucleoplasm and deposited 
on the inner aspect of the nuclear envelope; (B) A small-sized polygonal hepatocyte having a central irregular nucleus is seen in the CP 
group. The cytoplasm contains variable-sized of round and oblong-shaped mitochondria and dilated of rough endoplasmic reticulum, 
lysosomes. Macrophage (mac) also can be seen; (C) BCP group shows a similar normal hepatocyte as control group; (D) The polygonal 
hepatocytes being similar to the normal liver with the exception of a high mitochondrial number in the PmEO100CP group. The 
cytoplasm contains numerous oval and oblong mitochondria, rough endoplasmic reticulum and lysosome. The cell has a central oval 
nucleus with nucleolus, masses heterochromatin and cell membrane also can be seen; (E) PmEO200CP shows irregular structure of 
nucleus, increase number of round and oblong shape mitochondria, phagosome (ph) and macrophage also can be seen; (F) Small-sized 
of hepatocytes, vesicular dilated of RER and thick hepatocyte membrane were seen in PmEO400CP group; and (G) PmEO400 group 
shows a central irregular nucleus with a defect in its envelope. The cytoplasm contains variable size of mitochondria and lysome
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antioxidants, terpenoids and phenolic compounds including 
a-humulene, a-curcumene, β-caryophyllene, d-cadinene, 
farnesol and nerolidol that exhibit several bioactive 
properties (Ahmad et al. 2014; Baharum et al. 2010). 
BCP found in the essential oils of spices and medicinal 
plants such as cloves, origanum and cinnamon and black 
pepper (Gertsch et al. 2008); is a FDA-approved food 
additive, antioxidant (Bridgeman & Abazia 2017), anti-
inflammatory agent (Gertsch et al. 2008) and antispasmodic 
agent (Leonhardt et al. 2010). BCP effectively improved 
cisplatin-induced nephrotoxicity in a cannabinoid 2 
receptor-dependent manner (Calleja et. al. 2012) and the 
antioxidant effect of BCP protected rat liver from carbon-
tetrachloride-induced fibrosis (Hovárth et. al. 2012); and 
therefore was used as positive control in this study. Dose 
of BCP and PmEO is according to previous study by Cho 
et al. (2007) and Damião et al. (2013), respectively.
 The present study found that a single dose of 
cisplatin (10 mg/kg) induced toxicity symptoms including 
lacrimation, piloerection, hypoactivity and reduced food 
and drink intake in rats. In accordance with the present 
results, Abdelmeguid et al. (2010) also found that rats 
became slightly nervous, less active and exhibited minimal 
loss of furring after a single injection of cisplatin. Cisplatin 
also significantly decreased the body weights in the 
treated rats compared to the controls. Leite et al. (2009) 
also found that mice treated with high doses of cisplatin 
showed the extreme loss of body weight and postponed 
their recovery time. Chirino et al. (2004) also found the 
decrease of body weight in male rats after 3 days of single 
of i.p. injection of cisplatin. Reduction in body weight of 
cisplatin-induced rats might be a result of gastrointestinal 
dysfunction and toxicity (Mora et. al. 2003). According 
to King and Perry (2001), cisplatin-treatment might have 
contributed to weight loss in the rats. Likewise, Park et al. 
(2009) also found that the decrease of the body weight in 
cisplatin-induced rats may be because of tissue injury and 
reduction of their function. Moreover, the reduction in body 
weight of the animals in this study can be correlated with 
the decreased food intake observed during experimental 
period. In this study, the mean body weight of BCP and 
PmEO-treated rats also significantly decreased on the 
day 17 and 18 compared to the control group; suggesting 
treatments were unable to prevent cisplatin-induced weight 
reduction. 
 Cisplatin-induced hepatotoxicity is often characterized 
by minor-to-average increase in serum transaminases, 
and less frequently by average increase in serum alkaline 
phosphatase, bilirubin, g-glutamyl transpeptidase and 
lactate dehydrogenase levels. The serum levels of ALT and 
AST act as oblique assessment of liver condition because 
these enzymes are normally found in the cytoplasm and 
are only secreted into the circulation after hepatic damage 
(McGill 2016). In the present study, the capability of 
BCP, PmEO100CP and PmEO200CP in ameliorating 
the cisplatin-induced hepatotoxicity was observed from 
lowered level of transaminase enzymes in serum compared 
to cisplatin-induced rats. The amelioration of liver enzymes 
might be attributed to the effect of BCP, PmEO100CP 
and PmEO200CP on the hepatocyte cell death and 
membrane rupture, preventing AST and ALT leakage into the 
circulation. Unfortunately, PmEO400CP also significantly 
elevated ALP, AST and ALT compared to the control, BCP 
and PmEO100CP-treated rats. The dose of 400 mg/kg of 
PmEO might have potentiated cisplatin toxicity. Prapapan 
et al. (2013) also reported that levels of transaminase 
enzymes depend on the dose of sesquiterpenes zederone, 
isolated from Curcuma elata where the highest dose (200 
mg/kg) showed high level of transaminase enzymes and 
total bilirubin levels. 
 In the present study, a significant reduction in GSH 
levels, GPx, CAT and SOD enzyme activity with increased 
MDA level was observed in PmEO200CP and PmEO400CP 
and the better results were observed at the dose of 100 mg/
kg and BCP treatment in rats. Similarly, Christapher et al. 
(2016) has confirmed that P. minus methanol extract had 
protective effect at dose of below 200 mg/kg on carbon 
tetrachloride-induced hepatotoxicity. Iseri et al. (2007) and 
Mansour et al. (2006) showed a significant difference of 
oxidative stress biomarker (GSH, GPx, CAT, SOD and MDA 
in cisplatin-induced rats. The production of ROS induced 
severe cell damage and membrane permeability mediated 
by oxidative stress (Iseri et al. 2007). Therefore, cisplatin-
induced liver toxicity can be improved by increasing 
antioxidant such as GSH, GPx, CAT and SOD, as seen in 
this study (Palipoch et al. 2014). However, high dose of 
sesquiterpenes in PmEO200CP and PmEO400CP can 
become pro-oxidants in excessive concentration of their 
free form by reduction of its oxidized metal ions (Lee et 
al. 2013); suggesting why oxidative stress in essential oil-
treated groups were lower in PmEO100CP compared to 
and PmEO400CP groups.
 Protein carbonyl is a biomarker for protein oxidation. 
The present study found that protein carbonyl content 
is significantly increased in cisplatin and PmEO400CP-
treated rats compared to the control and BCP-treated rats. 
According to Waseem et al. (2017), protein carbonylation 
indicates oxidative protein damage resulting from 
cisplatin-induced oxidative stress. PmEO100CP and BCP 
pre-treated rats significantly restored protein carbonyl 
content in the liver similar to the role of natural product 
on protein carbonylation previously shown by Mohamed 
et al. (2013). 8-OHdG is the most significant indicator of 
DNA damage (Koyuncu et al. 2017). According to Cadet 
(2014), hydrogen from nucleic acids being eliminated by 
hydroxyl radicals or reacted with double bonds may lead 
to production of 8-OHdG. Our results demonstrated that 
8-OHdG is significantly increased in cisplatin-treated 
rats as compared to the control group. Previous studies 
showed that DNA damage was significantly inhibited by 
pre-treatment with natural compounds (Ince et al. 2014; 
Koyuncu et al. 2017). PmEO100CP and BCP likely used its 
antioxidant activity and decreased ROS-mediated 8-OHdG 
production. 
 In the present study, the biochemical and oxidative 
stress results were confirmed by histological observations. 
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Similar to El-Sayyad et al. (2009), this study also found 
many histological abnormalities including inflammatory 
infiltration, marked disruption of hepatic cords and 
dilated blood sinusoids in the rat livers following cisplatin 
injection. BCP and PmEO100CP ameliorated most of these 
findings. However, PmEO200CP were more deleterious 
compared to PmEO100CP whereby mild dilated blood 
sinusoids, increasing number of binucleated hepatocytes 
and Kupffer cells were observed. PmEO400CP also 
showed similar destruction of hepatocytes as in the 
cisplatin-induced rats. This might be due to the presence 
of some sesquiterpenes in high concentration as stated 
by Prapapan et al. (2013). At a dose of 200 mg/kg, 
hepatocytes necrosis was spread toward the portal area 
and accompanied by major haemorrhage. Furthermore, 
Prapapan et al. (2013) also suggested the potentiation of 
zederone (sesquiterpene)-induced liver toxicity involved 
the induction of cytochrome P450 that leads to the 
formation of biological reactive metabolites and oxidative 
stress. Ultrastructural study also showed that hepatocytes 
with vesicular dilated RER, irregular nuclei and many small 
mitochondria in the cisplatin-induced rats, PmEO200CP 
and PmEO400CP groups. Additionally, mitochondrial 
number in the cisplatin, PmEO200CP and PmEO400CP 
group were increased, varying from small round to long 
rod shaped. 
CONCLUSION
In conclusion, the results of the present study showed 
that, PmEO100CP restored the biochemical, histological 
and ultrastructural changes of cisplatin-induced liver 
toxicity in rats. PmEO100CP protected against cisplatin-
induced hepatotoxicity in part through their antioxidant 
activity. Further studies are warranted to explore the 
precise mechanism underlying the preventive effect of 
PmEO100CP. 
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